Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal preparation of coenzyme Q10 liposome and its preparation technology

A technology of pharmaceutical preparations and liposomes, applied in the field of medicine, can solve problems such as low bioavailability and inconvenience for patients to swallow, and achieve the effects of improving bioavailability, improving passive targeting, and improving therapeutic effects.

Inactive Publication Date: 2006-08-30
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

current coenzyme Q 10 The oral dosage forms are mainly tablets, capsules, soft capsules, etc. These dosage forms have problems such as inconvenient swallowing and low bioavailability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal preparation of coenzyme Q10 liposome and its preparation technology
  • Medicinal preparation of coenzyme Q10 liposome and its preparation technology
  • Medicinal preparation of coenzyme Q10 liposome and its preparation technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] coenzyme Q 10 50mg, soybean lecithin 300mg, cholesterol 300mg, pH6.5 phosphate buffer 10mL.

[0059] Coenzyme Q 10 , soybean lecithin, and cholesterol in a pear-shaped bottle, add 30 mL of dichloromethane, heat to dissolve, put it on a rotary evaporator, remove the dichloromethane under reduced pressure in a water bath at 60°C, add phosphate buffer, continue to rotate for 1 hour, and Extrude through 0.8m filter membrane to get coenzyme Q 10 Liposomal oral solution.

Embodiment 2

[0061] coenzyme Q 10 10mg, egg yolk lecithin 60mg, cholesterol 30mg, Tris buffer solution of pH 7.5 10mL.

[0062] Coenzyme Q 10 , egg yolk lecithin, cholesterol, add 2mL ethanol to dissolve, put the Tris buffer solution in a three-necked bottle, inject the lipid solution into the buffer solution at 50°C in a water bath, and squeeze out through a 0.2m filter membrane to obtain coenzyme Q 10 Liposomal injections.

Embodiment 3

[0064] coenzyme Q 10 15mg, soybean lecithin 100mg, cholesterol 20mg, pH6.7 phosphate buffer 10mL.

[0065] Coenzyme Q 10 , soybean lecithin, and cholesterol were placed in a pear-shaped bottle, added 10 mL of chloroform to dissolve, placed on a rotary evaporator, and decompressed in a water bath at 40°C for 5 minutes until gelatinous, added 10 mL of phosphate buffer, continued to rotate for 1 hour, and Extrude through a 0.45m filter membrane to obtain coenzyme Q 10 Liposome injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

A liquid medicine in the form of oral liquid or injection contains coenzyme Q10, liposome and buffer liquid proportional. It has high stability and biologic utilization rate.

Description

technical field [0001] The present invention relates to coenzyme Q 10 A liposome and a preparation method thereof belong to the technical field of medicine. Background technique [0002] coenzyme Q 10 (coenzyme Q 10 , CoQ 10 ) is an endogenous substance in animals. It exists in the inner membrane of mitochondria. It is a hydrogen transporter in the respiratory chain, an activator of cell metabolism, and an essential substance for the human body to maintain life. It passes through the inner membrane of mitochondria in the body. The role of the system is synthesized from p-hydroxybenzoic acid and isopentenyl pyrophospholipids. endogenous coenzyme Q 10 The total content in the human body is 0.5-1.5 mg, and the level in the heart, liver and pancreas is relatively high, and it has the function of binding proteins. Clinical studies have found that exogenous coenzyme Q 10 It has antioxidant and cell membrane stabilizing effects, can maintain the internal and external environ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/122A61K9/127A61P9/04A61P9/06A61P9/10A61P9/12A61P1/16A61P1/04A61P11/00A61P35/00
Inventor 邓英杰李喆
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com